Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Declaration of patient consent: The authors certify that they have obtained all appropriate patient consent forms
49:W6718
Pregnancy and Lactation: Safe for use, but always consult with healthcare professionalsthe benefits must outweigh the inherent risks
US$ 25.08
US$ 26.90
US$ 28.83
US$ 22.09
